These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 11446562)
21. Evidence that treatment with risedronate in women with postmenopausal osteoporosis affects bone mineralization and bone volume. Fratzl P; Roschger P; Fratzl-Zelman N; Paschalis EP; Phipps R; Klaushofer K Calcif Tissue Int; 2007 Aug; 81(2):73-80. PubMed ID: 17612779 [TBL] [Abstract][Full Text] [Related]
22. Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis. Rossini M; Gatti D; Zamberlan N; Braga V; Dorizzi R; Adami S J Bone Miner Res; 1994 Nov; 9(11):1833-7. PubMed ID: 7863833 [TBL] [Abstract][Full Text] [Related]
23. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial. Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377 [TBL] [Abstract][Full Text] [Related]
24. Long-term continuous combined hormone replacement therapy in the prevention of postmenopausal bone loss: a comparison of high- and low-dose estrogen-progestin regimens. Heikkinen J; Vaheri R; Kainulainen P; Timonen U Osteoporos Int; 2000; 11(11):929-37. PubMed ID: 11193245 [TBL] [Abstract][Full Text] [Related]
25. The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy. Hildebolt CF; Pilgram TK; Yokoyama-Crothers N; Vannier MW; Dotson M; Muckerman J; Armamento-Villareal R; Hauser J; Cohen S; Kardaris EE; Hanes P; Shrout MK; Civitelli R J Periodontol; 2002 Nov; 73(11):1279-84. PubMed ID: 12479631 [TBL] [Abstract][Full Text] [Related]
26. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial. Bunyavejchevin S; Limpaphayom KK J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499 [TBL] [Abstract][Full Text] [Related]
27. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen? Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075 [TBL] [Abstract][Full Text] [Related]
28. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial. Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236 [TBL] [Abstract][Full Text] [Related]
29. The effect of tibolone on bone mineral density in postmenopausal women with osteopenia or osteoporosis--8 years follow-up. Prelevic GM; Markou A; Arnold A; Bartram C; Puzigaca Z; Ginsburg J Maturitas; 2004 Mar; 47(3):229-34. PubMed ID: 15036493 [TBL] [Abstract][Full Text] [Related]
30. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength. Fox J; Miller MA; Newman MK; Metcalfe AF; Turner CH; Recker RR; Smith SY Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596 [TBL] [Abstract][Full Text] [Related]
31. Increase in bone mass of older postmenopausal women with low mineral bone density after one year of percutaneous oestradiol implants. Holland EF; Leather AT; Studd JW Br J Obstet Gynaecol; 1995 Mar; 102(3):238-42. PubMed ID: 7794850 [TBL] [Abstract][Full Text] [Related]
32. Measurement of bone mineral density (BMD) with quantitative computed tomography (QCT) in postmenopausal osteoporosis: effect of estrogen. Zgliczyński S; Szulc P; Słowińska-Srzednicka J; Stopińska-Głuszak U; Misiorowski W; Jeske W; Snochowska H; Wagiel K; Walecki J Endokrynol Pol; 1992; 43(3):350-7. PubMed ID: 1345576 [TBL] [Abstract][Full Text] [Related]
33. [Effect of estriol and bone mineral density of lumbar vertebrae in elderly and postmenopausal women]. Nishibe A; Morimoto S; Hirota K; Yasuda O; Ikegami H; Yamamoto T; Fukuo K; Onishi T; Ogihara T Nihon Ronen Igakkai Zasshi; 1996 May; 33(5):353-9. PubMed ID: 8741364 [TBL] [Abstract][Full Text] [Related]
34. Bone remodeling and structure in postmenopausal women treated with long-term, high-dose estrogen therapy. Vedi S; Purdie DW; Ballard P; Bord S; Cooper AC; Compston JE Osteoporos Int; 1999; 10(1):52-8. PubMed ID: 10501780 [TBL] [Abstract][Full Text] [Related]
35. The importance of estrogen replacement in young women with Turner syndrome. Hanton L; Axelrod L; Bakalov V; Bondy CA J Womens Health (Larchmt); 2003 Dec; 12(10):971-7. PubMed ID: 14709185 [TBL] [Abstract][Full Text] [Related]
36. Influence of estrogen therapy at conventional and high doses on the degree of mineralization of iliac bone tissue: a quantitative microradiographic analysis in postmenopausal women. Boivin G; Vedi S; Purdie DW; Compston JE; Meunier PJ Bone; 2005 Mar; 36(3):562-7. PubMed ID: 15777681 [TBL] [Abstract][Full Text] [Related]
37. Long-term effects of percutaneous estradiol on bone loss and bone metabolism in postmenopausal hysterectomized women. Devogelaer JP; Lecart C; Dupret P; De Nayer P; Nagant De Deuxchaisnes C Maturitas; 1998 Jan; 28(3):243-9. PubMed ID: 9571600 [TBL] [Abstract][Full Text] [Related]
38. Early effects of hormone replacement therapy on bone. Patel S; Pazianas M; Tobias J; Chambers TJ; Fox S; Chow J Bone; 1999 Mar; 24(3):245-8. PubMed ID: 10071917 [TBL] [Abstract][Full Text] [Related]
39. The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis. Bertonazzi A; Nelson B; Salvador J; Umland E Womens Health (Lond); 2015 Nov; 11(6):815-24. PubMed ID: 26618621 [TBL] [Abstract][Full Text] [Related]
40. Five-year changes in bone density, and their relationship to plasma estradiol and pretreatment bone density, in an older population of postmenopausal women using long-term estradiol implants. Vashisht A; Studd JW Gynecol Endocrinol; 2003 Dec; 17(6):463-70. PubMed ID: 14992165 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]